A promising injectable for HIV prevention
A “significant breakthrough” in HIV prevention could be on the horizon, according to the World Health Organization. Results of an interim analysis from a Phase 3 clinical trial sponsored by Gilead Sciences, Inc., showed that lenacapavir, a twice-yearly …